Department of Clinical Chemistry and Haematology, University Medical Center Utrecht, Heidelberglaan 100, 3584 CX Utrecht, The Netherlands.
Proc Natl Acad Sci U S A. 2010 May 18;107(20):9083-7. doi: 10.1073/pnas.1004741107. Epub 2010 May 3.
The mechanism by which the intrinsic pathway of coagulation contributes to physiological hemostasis is enigmatic. Thrombin activates factor XI, a key zymogen in this pathway, which leads to increased thrombin generation. As thrombin-dependent activation of factor XI in vitro is relatively inefficient, we hypothesized that a physiological cofactor supports this reaction in a plasma environment. We therefore investigated whether the cofactors of coagulation, activated factor V, activated factor VIII, high-molecular weight kininogen, or protein S, influenced activation of factor XI by thrombin. Only activated factor V stimulated activation of factor XI by thrombin in a purified system. Binding studies demonstrated that factor XI specifically interacts with both factor V and factor Va through multiple binding sites. We further investigated this cofactor function of activated factor V in plasma. Depletion of factor V, or the addition of activated protein C, decreased the activation of the intrinsic pathway by thrombin in plasma. However, activated protein C did not exert this effect in the plasma of a homozygous carrier of the prothrombotic factor V Leiden mutation. In conclusion, we propose a role for (activated) factor V as a cofactor in the activation of factor XI by thrombin. These findings offer insights into the coagulation system in both health and disease.
凝血固有途径促进生理止血的机制尚不清楚。凝血酶激活因子 XI,这是该途径中的关键酶原,导致凝血酶生成增加。由于体外凝血酶依赖性因子 XI 的激活相对效率较低,我们假设在血浆环境中存在一种生理辅助因子来支持该反应。因此,我们研究了凝血辅助因子,如激活的因子 V、激活的因子 VIII、高分子量激肽原或蛋白 S 是否影响凝血酶对因子 XI 的激活。只有激活的因子 V 在纯化系统中刺激凝血酶对因子 XI 的激活。结合研究表明,因子 XI 通过多个结合位点特异性地与因子 V 和因子 Va 相互作用。我们进一步研究了激活的因子 V 在血浆中的这种辅助因子功能。因子 V 的耗竭或激活的蛋白 C 的添加降低了血浆中凝血酶对固有途径的激活。然而,激活的蛋白 C 并未在携带易栓症因子 V 莱顿突变的纯合子携带者的血浆中发挥此作用。总之,我们提出(激活的)因子 V 作为凝血酶激活因子 XI 的辅助因子的作用。这些发现为健康和疾病中的凝血系统提供了新的认识。